share_log

Jörn Jörgensen Buys Handful Of Shares In EuroEyes International Eye Clinic

Jörn Jörgensen Buys Handful Of Shares In EuroEyes International Eye Clinic

Jörn Joörgensen 購買了 EuroEyes 國際眼科診所的少量股票
Simply Wall St ·  2023/12/07 17:09

Those following along with EuroEyes International Eye Clinic Limited (HKG:1846) will no doubt be intrigued by the recent purchase of shares by Jörn Jörgensen, Founder of the company, who spent a stonking HK$7.8m on stock at an average price of HK$5.19. While that only increased their holding size by 0.8%, it is still a big swing by our standards.

關注者以及EuroEyes國際眼科診所有限公司(HKG:1846)無疑會被該公司創始人約恩·約爾根森最近購買股票所吸引,他花費了780萬港元的驚人股票,平均價格爲519港元。儘管這僅使他們的持股規模增加了0.8%,但按照我們的標準,這仍然是一個很大的波動。

View our latest analysis for EuroEyes International Eye Clinic

查看我們對EuroEyes國際眼科診所的最新分析

The Last 12 Months Of Insider Transactions At EuroEyes International Eye Clinic

EuroEyes 國際眼科診所最近 12 個月的內幕交易

Notably, that recent purchase by Jörn Jörgensen is the biggest insider purchase of EuroEyes International Eye Clinic shares that we've seen in the last year. That implies that an insider found the current price of HK$5.30 per share to be enticing. Of course they may have changed their mind. But this suggests they are optimistic. If someone buys shares at well below current prices, it's a good sign on balance, but keep in mind they may no longer see value. Happily, the EuroEyes International Eye Clinic insiders decided to buy shares at close to current prices.

值得注意的是,約恩·約爾根森最近的收購是我們在去年看到的最大規模的內幕收購EuroEyes國際眼科診所的股票。這意味着一位內部人士發現目前每股5.30港元的價格很誘人。當然,他們可能已經改變了主意。但這表明他們持樂觀態度。如果有人以遠低於當前價格的價格購買股票,那麼總體而言,這是一個好兆頭,但請記住,他們可能不再看到價值。令人高興的是,EuroEyes國際眼科診所內部人士決定以接近當前的價格購買股票。

Over the last year, we can see that insiders have bought 2.77m shares worth HK$15m. But insiders sold 5.00k shares worth HK$29k. Overall, EuroEyes International Eye Clinic insiders were net buyers during the last year. You can see a visual depiction of insider transactions (by companies and individuals) over the last 12 months, below. If you click on the chart, you can see all the individual transactions, including the share price, individual, and the date!

在過去的一年中,我們可以看到內部人士購買了價值1500萬港元的277萬股股票。但內部人士出售了價值2.9萬港元的500萬股股票。總體而言,去年,EuroEyes國際眼科診所的內部人士是淨買家。你可以在下面看到過去 12 個月內幕交易(由公司和個人進行的)的直觀描述。如果你點擊圖表,你可以看到所有的個人交易,包括股價、個人和日期!

insider-trading-volume
SEHK:1846 Insider Trading Volume December 7th 2023
香港交易所:1846 內幕交易量 2023 年 12 月 7 日

EuroEyes International Eye Clinic is not the only stock insiders are buying. So take a peek at this free list of growing companies with insider buying.

EuroEyes國際眼科診所並不是業內人士唯一買入的股票。因此,來看看這份包含內幕買入的成長型公司的免費名單吧。

Insider Ownership Of EuroEyes International Eye Clinic

EuroEyes 國際眼科診所的內部所有權

Another way to test the alignment between the leaders of a company and other shareholders is to look at how many shares they own. Usually, the higher the insider ownership, the more likely it is that insiders will be incentivised to build the company for the long term. EuroEyes International Eye Clinic insiders own about HK$1.0b worth of shares (which is 57% of the company). Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.

檢驗公司領導者與其他股東之間一致性的另一種方法是查看他們擁有多少股票。通常,內部人所有權越高,內部人士被激勵長期建立公司的可能性就越大。EuroEyes國際眼科診所內部人士擁有價值約10億港元的股份(佔該公司的57%)。大多數股東會樂於看到這種內幕所有權,因爲這表明管理層的激勵措施與其他股東非常一致。

What Might The Insider Transactions At EuroEyes International Eye Clinic Tell Us?

EuroEyes 國際眼科診所的內幕交易會告訴我們什麼?

It is good to see the recent insider purchase. We also take confidence from the longer term picture of insider transactions. Along with the high insider ownership, this analysis suggests that insiders are quite bullish about EuroEyes International Eye Clinic. That's what I like to see! If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

很高興看到最近的內幕收購。我們也從內幕交易的長期前景中獲得信心。除了較高的內部所有權外,該分析還表明,內部人士對EuroEyes國際眼科診所非常看好。這就是我喜歡看到的!如果你像我一樣,你可能需要考慮這家公司是會成長還是會萎縮。幸運的是,你可以查看這份顯示分析師對其未來的預測的免費報告。

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

如果你想看看另一家公司——一家財務狀況可能優越的公司——那麼千萬不要錯過這份免費的股本回報率高、債務低的有趣公司的名單。

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.

就本文而言,內部人士是指向相關監管機構報告其交易的個人。我們目前只考慮公開市場交易和私下處置的直接利益,不包括衍生品交易或間接權益。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂?直接聯繫我們。 或者,給編輯團隊 (at) simplywallst.com 發送電子郵件。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論